Association Innovative Medicines Association Innovative Medicines: the association for innovative medicines in The Netherlands - is the industry association for the Dutch branches of innovative pharmaceutical companies. The association is not active in the field of generic or non-prescription drugs but is strongly involved with companies focused on biotechnological medicines.Tasks The principle tasks are: advocacy (influencing of measures taken by government and other parties which impact on the sector), service (in the form of providing advice), and information (about important societal trends and how to respond to them). ImageIn addition, an important task is the balancing of public opinion of the sector with reality, resulting from changes that have occurred in recent years. MembersThe Association Innovative Medicines has 43 members (see our list of members). Association, board and officeThe board of the association is made up of seven General Directors of affiliated companies. The composition of the board is a reflection of the different segments of the association, so that all types of companies are represented. The office has 24 employees. The staff members are highly qualified experts in the fields of economics of health care, pharmaceutical affairs, innovation, biotechnology, medical-scientific issues, legal affairs and communication. Through working groups the employees of member companies are actively involved in policy-development. About the Association Innovative Medicines The association promotes its members' interests in pharmaceutical research and the pharmaceutical industry. It follows government policy closely, responds actively to relevant plans, measures and decisions, and contributes to the social debate about the added value of innovative pharmaceutical products. The association consults with care insurers, prescribers, care authorities, politicians and government, and advocates policy that encourages investments, new technologies and innovation. The association translates laws and regulations into practice, assists in legal issues and provides information and advice using practical means such as meetings, brochures, this member network and the electronic newsletter. Protection of InterestsThe association's main task is to demonstrate the sector's importance to health care and, using its clout, to influence any planned decisions. The association's lobby work is aimed at creating the best possible conditions for developers and manufacturers of innovative medicines to thrive.